# title<TAB>url
# Generated by scripts/ci_capture_playwright.py
Regular Exercise Reduces Atrial Fibrillation Recurrence by Nearly 50% After Catheter Ablation, Study Shows	https://news.google.com/read/CBMirgFBVV95cUxPaUNjc2RXQnpvZHZGamlsd2pYWTBGazMtLUxkNUpsU3F1MnRwV2UzODV2SHZXeTd5OFpWUENaTGFsa3lOYTcxQUxIbC1mN0VnSTVnNzZRa05Rb2dSdkk0Y01KMUVsaWtqT1RVV2hzaDNtUWZRLUZ5Njl4dF9OZFoxUFc4RGxJNlRzX19QOGRnRmZWMnFmMVE2MGdvRS14bmpmS0JmQlNOMkhnSk1EUmfSAb4BQVVfeXFMTk9OODF1TUxlSGdqcDFtczVrekdsUXd3dnVWVGItVXhhTDU4MUU4ZFhySzdXR3RyMmdpc1BQcGl1eklxbFFPTjFYMXdDTk9pQU8xak9sNHI1a00zS1h6N3kxMk9Rb0dnNkdkQUpZMlRMZHQzVjY2NGlFdHp0akk2S2NOSTJMLVJtbExvcG9pQlZ6aFNwQlBuSjBxTGNuNXhWY0JkLU1ZaldCeDhNN1pjdUQ3NGVUNkNYMDk5YzF4UQ?hl=en-US&gl=US&ceid=US%3Aen
Improving Outcomes for People with Atrial Fibrillation	https://news.google.com/read/CBMiigFBVV95cUxPMFR2TURTRGVjdGFnRzdscWRjTUJkUVYtTUdKMHpFNE9iaDlLUlVKNkowSVIxdS15TkVQa2tnTHItSVFWaTdtMG1FeFZaVTdia05BVTJNMFFQVWF0dWFXN0pHWVFZLWx1cVdDdHh5M3hlM1ZqcUwwMEhLRXRBZ0ZfNHpKaTdYSVR5OHc?hl=en-US&gl=US&ceid=US%3Aen
UChicago cardiologist rethinks devices used to prevent stroke in patients with AFib	https://news.google.com/read/CBMi6gFBVV95cUxQNzJRdnU4b1BCUnNvc3ZIekFjdFBvV0RiaHphTmxkYkZ3c1FmWUFhV0twdFFFX3lVbTVYQnZpbmFZZl9zREtDa0lSMXRCYzc5WWFtWkVqdnlyZ3NMSHI2eFpzelh1aFo4R1lhRDlvdzZxcXVNTW5BZC1GelB1Q0tLb282SFpHSU5wZ1FFdlk0aEM0ZlBKb0p2VmU3RWF1MDRUZU1VNFJQNUZFN1BPVkNWMi1TZTEteWpyYTZGc2Y1bWJKemNtYV9QWFZqcFhkUzBnOVB3MkJkaUMxRkxNTkIwZENPTmNVQzVDbkE?hl=en-US&gl=US&ceid=US%3Aen
4 takeaways from the 2026 AF Symposium	https://news.google.com/read/CBMijwFBVV95cUxPcGF5di1rTjJyeldNTTRRaS0zVl80eVVBTTdUWkxMRDhuVDNXTTBQTlJMa2FqX3RZMHRwU21xQnZyVDNUN2lqUVhzUElSRDhOTkRWYUdGMWI2SkJmNlVXSWZKY21uWndncVZCanRycjBtYmdvN1JSM1Zma0R2d2xPZHNnNVotUWxkdDJIenI5Yw?hl=en-US&gl=US&ceid=US%3Aen
Pulse Field Ablation reshapes AFib care in Rochester	https://news.google.com/read/CBMid0FVX3lxTE8wNFhyYVNkWWd6TlRzN3BxQi16dGUxaHFOQzZuaFJ0SjFWN0ZLSE1pdVFoYWxMMGlJLXhWQTlHamEwX1lJZnJKT3VadktkZEdWR0l2THV4THlYMkx0ZnJMWUQyNFZXNUdPM0h3SUhONmxkRTFXUTJV?hl=en-US&gl=US&ceid=US%3Aen
New technology at UVA Health offers safer treatment for atrial fibrillation	https://news.google.com/read/CBMi7AFBVV95cUxPTEZaRUczeG1WTWRYaDdscUlYN1liTmxaNXJRMDd5dmx6ZjUtMVNuU0laemt2VGI3bHQza1B0OUswbnE2T3VycWxGQm1iZWJjN0JMeEpLcWYtQlRZN1F3aDdEUVV4QzdlNmVaeG9vY2NnNlVfMzJNektoNUFZNEF2NGtEN2xaUUZfb1BydDNzaXFzVk96YWsxdy1yWXdpNzFIR3FSQXpGbjFFa2JyX3VPUUU5VmtZaUd5bVFpektwOGJnQlhIRXl2WGdNZGtCMmE3VXBvYTFCX3JpdFdaZXVGUXhBejZjNnQyN2ZZdA?hl=en-US&gl=US&ceid=US%3Aen
Abbott initiates UK pilot of Volt PFA system	https://news.google.com/read/CBMikgFBVV95cUxOSlYtYXppNjlkSGYzNWN0dHJqMGRFNnluU1UtVUZxVExCWkdjWEFRd1dzREt1OVgtanU4cUNzUG5TbS1wVFlPcHVrWC05UldVMXhpTjhVRUR2LTdrYlFjV1JpREk0Sy1GTlI5dDdkNGJkWnM2LS1zLXVnbW0tU2ZiN2kwRHRId2p0OTBZNlFBNGNyQQ?hl=en-US&gl=US&ceid=US%3Aen
Atrial fibrillation rising among young adults, new depression treatments, and Friday the 13th fears: Daily Dose	https://news.google.com/read/CBMivwJBVV95cUxObVV5d3ZzVFFQWlZtU19GcFp6TGxZdEsxMmdMM1dIb2tJcUdscHZsaGJUa0FEd1p5SnJiNzFKZ1dYV05zOXhoVU5OeW1FTElwSEVrYjJjUnVENlhDeEhId3MyN2ZqNEFWZTdTdWZPNVJxMERIYVM1RkdUemU2dkNPcHBKNlltNThFcTU4RVVQeTdOTW5kR1A0NVVid3NKZmZfQUdxMXVoU3VjMDRXSVVaWXY0aFhMUjViTnc0WjhuTVFIVUVpcThtS1pXZXRIdDcwelZscHBKN2hXQTQzSVNxREtOOTNIamVHQ3hHc3RYeDk5c0ZFbllfTGlFS3ZpdjN0Ui1DX1pWV0RVZmtoVmlNZU9RSmJpbFdxLWxURFM3RVFldDQtUmR5eV9ja1VDbzFIMXNDeHQ2T2tkSm1BSUpR?hl=en-US&gl=US&ceid=US%3Aen
Early Findings on Implantable Device Look Promising	https://news.google.com/read/CBMipwFBVV95cUxOZTMydmViZkhURGxhQzI0eks0R0VLalEwcWNZYU5ZRG41Sng3aEo5enlKQVNKMlB3Qks0SGp0d2RNNnFSeTVIdkNwaW9ONUtLNTlRYXIzWHRXYkxETm16SC01OHpWdFRDc1BHTXNsZHhLbGcwajZZSlB1aVpUQ2Z1d1VjYno3Uk9OY3MzYm1aVmg0bzdHYjA2bG5UZVVjR0RWOWtNa21GMA?hl=en-US&gl=US&ceid=US%3Aen
Clinical trials may pave way for some AFib patients to safely get off blood thinners	https://news.google.com/read/CBMiuwFBVV95cUxPMUF3RjJnMlBVZENRSUJ5VWdjZXM0RUJSYUVPbVdlYzRDbXF4ZVh5aUctN2RRSnY3Y2M3R05tM2VnajhWc1l1RnNRN0VSQXkxY1Exa0VZRnZkMEFIQjR2NXl1R1pmOVd6UHQwd1MzOTEwRk9odWZ5Nk5RYy1zY2M5VWxoT01kaWQ0ZElQY0ZmeXgyRFp6c0I1blBYMzNtNnBZdTJDUmhSLWdUSHJfUEdrMnNrVFdVeHBMN05R?hl=en-US&gl=US&ceid=US%3Aen
Understanding AFib and New Advances in Treatment with Pulsed Field Ablation	https://news.google.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?hl=en-US&gl=US&ceid=US%3Aen
The biggest cardiac tech news out of the 2026 AF Symposium	https://news.google.com/read/CBMidEFVX3lxTE5qT2tDb2F4WmZEN3ZpREVJTmpGaEhBRzJjRW93aF9LX3l4d21NYTlMSUVkbDFlYWllZExXdVBlUFlhYk9oYXNZQV95eDdNaURfMnhmZzRla25KZERpWlQxUHF5LVY1V1NOa3Q2M2tRandoY2tV?hl=en-US&gl=US&ceid=US%3Aen
Boston EP Party: Medtech companies share new electrophysiology data at AF Symposium 2026	https://news.google.com/read/CBMi4wFBVV95cUxNNGEzdlBTUzVYTEtOOFhpZXJrbWNEU2NxdWJSeVQ3STF6dE5XMm85RWtBRTZsTl9KZFJRZjhBcDd0bkIxNDdSaU1qYU8xc2tuOERSUXVKMUhpcThWRERZQUNWaThiZ2RsTWxLQlBia3B6dEg2ajJhemd4TVp4NE5kTl9aVWtfOVphXzZDNXlMM2doN25PUGtINDU2WmVmeE9YSTJQVEFScktHYjRNUHhxNVB6SWc3dHdRTmY2R3gxbktsRGdEWEx6WWZ5ZEZUSWNzbl9ZRTRUSWFHMkJIemh2Ulk1UQ?hl=en-US&gl=US&ceid=US%3Aen
Aspirus discusses option for AFib	https://news.google.com/read/CBMiugFBVV95cUxPYm96NHV1ZU1YWEEtMlZkbzRZc0o4MG9KbmZlb0pKVzhEeDZiLURoLXE2a0RlRURPZ1VESzZvMlk0QThMYXB2R0h5M3gzNnNxcEpTRFg5TjhqM2p3akg5MjhDalpRc3ZTSUswU1Jpc2preWMybEg1a3FKS2F3R3VydlR5b2JTQWRSNlpsSWdXb19mc3RmTzFuSTZwWkRWazVYUW5NeDZ0c2dyRzhXNW1LRTAzRUFWY21OVUE?hl=en-US&gl=US&ceid=US%3Aen
2025's top 10 clinical trial flops	https://news.google.com/read/CBMie0FVX3lxTE56ZW4wOThDQmJaMVYwN3F0NG9Mcm9JdkNkZFhBcjF1SnVEMWllYUNmUHlsLVJYeTRvZllPaDNVNmZ0QWtTOXdhdHJnM1dXN3Zfd3BodkV1dG82SEtNdWhNbFFUX1dhMzJtLUpXNVZCeHhvM3ZrVFlWcDF2MA?hl=en-US&gl=US&ceid=US%3Aen
Non-contractile heart cells help sustain persistent atrial fibrillation, study reveals	https://news.google.com/read/CBMijwFBVV95cUxOM1lpOWRBaWJNbzU3RFpMa0NmUTE5akF4ejVoQ2RudWZFOElYS2o2QjNIWFNTVlpnWkRFQ3pHajVEakdRSTJuRE5HWVQ5R1ZsNjdlY0NraW5OVEp1dDEtYm0tN2VGRW5EeW84ZlJjU0VuYzRMTUUtVzVzYkZCVTZwNmRHdUpPZWNNc0lRSk96NA?hl=en-US&gl=US&ceid=US%3Aen
Boston Sci’s Farapulse better than thermal ablation at 4 years	https://news.google.com/read/CBMipAFBVV95cUxPc0dyYl9kWC1oanduS3BzUnBFV1E5bENjLVlmWDVxRlBTc3NLMDRJQ2lsdUpfb1VMbjYtdUd0TnVTUF9JdXZ6cVA1aVBVa3RsaWI2N1dwTkFhZ2h6alZCYm80VS1nSm9RcFJnTWk2cWJvUWdMX3NFQ0l6eEFVY3hDSWEwT2ljNWhYLWpMU19jRDlTSjJJRHJNMTc0OXVxanRNaVpyOQ?hl=en-US&gl=US&ceid=US%3Aen
Johnson & Johnson reports early pilot study results for atrial fibrillation device	https://news.google.com/read/CBMi2wFBVV95cUxOSzJqT3k3WjQwcldNS3ZBc2RTUGN1RjJnZGxzLURRQ1kzaDR3VjNrX2ZDRmZ5Qkh6Ulh0N0IxY2ptRnBKclNnTnVoRkpGbXZkNENPSF9sb2s4ZzRSQ0U1TjhXSXFzUGpjeUd5ZWZoMEFSeXhyaXl6bFpnQ054djM3UDRYQ21KTDYzVTRMRWVQY3JLUDBFUmNzR0lsejVkcmpJT0s3cXBpNXc5ZmZFZld3Y184dFo5TEh0U3BsQ0Frc25QOGprQzBENHlJLXNXMGxHekg3MUhDZ1YzczA?hl=en-US&gl=US&ceid=US%3Aen
Abbott reports positive VERITAS study results for AFib	https://news.google.com/read/CBMihwFBVV95cUxNY29aemp5NnhaQXIxVWR6dzdvZ0E2c1V3a1luSnJNcGd6N0VvZjNXQXVqRXVSdDRGVzNBSFZWTVVqWUtmSWNvRXpXT0YtbVpIVTlYUXVtYjcwRlZUYzZGVjJvdEhBbEstejRCZTc2U3hXUlVpNlBJMFkwS0tlQUlVaXJkX3Q1TlU?hl=en-US&gl=US&ceid=US%3Aen
Abbott details Volt, TactiFlex data; Pulse Biosciences’ results shine	https://news.google.com/read/CBMikwFBVV95cUxNNUlJa1hLb09YanZ6Nk53Vk9DMVlrcTF4TGlGTGdmSFBnaERQSjk2RHQ3QnJjMkpReXNINHZHTnlrcmF3bUdfdjgteFdYMU9leGRtVWNCRm4ya244MDlxMVdlaGRVODItMzNBT0c0S2FSODBUTGdEYWJyam5JLWI4c0xjQThkbV9PanRBLXp6eTNrbVE?hl=en-US&gl=US&ceid=US%3Aen
Kadlec now offers stroke-preventing WATCHMAN device in Tri-Cities	https://news.google.com/read/CBMi4gFBVV95cUxPUlgxZXM1ZHdaTGRialhOOW5qdWx5a3hYS21xbktjLVlobmQ4SEExNkdRaDJucXd0NHhJSkZYU2NOSi1oR0RiWGdhUGoxdGpwcDVjdlhCNENKQlBPUVBRMVpoQ080Y2g5c1JCRENkY0xwVV9ub2xiTHhfTWtGTnJDMHFLa29CUmdUVkdSZndFQ19YaHdxY2tuakZBRkw4RTUyTFpTSEFSaVJGc2dsUDFZQ3RUT0daT25kMEVMT3pZOU90eWl2NUhPWjFnNUpvZ0RHblFEY0QwOFpLSVBZTUQ3RHVR?hl=en-US&gl=US&ceid=US%3Aen
NHS hospitals pilot Abbott Volt PFA system	https://news.google.com/read/CBMiiwFBVV95cUxOY0pVUzdmYk0wSC0yeXZEOHVmRVNCUVU4MjJmQnZQaHlIMUVTQlpwdERrV3NVR2Npc2Jka3RJRWtGNjJNN3BmRG1nWktWRTdjeFNPcjVCaF8zbGkza1VaWm9LczFMYjVJekZvZXQyNGpnSU9EdkJodkhNZTlZZ2NyaGpPMEJmU25VT3ZF?hl=en-US&gl=US&ceid=US%3Aen
Pulsed Field Ablation Market Size, Share, Growth | CAGR of 33.2%	https://news.google.com/read/CBMiZEFVX3lxTE9DX3lZc21fZk03YUN3bTEwWm1rdzVSb05iRURjUWxIcDdiejQxa0JqNnpoRTl6aUFLTWNVUGp1QVJRN3ExM2RnWmV6eXplaHhyZ2VhVk1qM0YzQUt3VmhnYm5USVA?hl=en-US&gl=US&ceid=US%3Aen
Smartphone-Sensor System Not Yet Ready to Detect Arrythmia in High Risk Patients	https://news.google.com/read/CBMiXkFVX3lxTE13T0E0amZ2MER2dmc4eU1xZE9YNnZwTVV3R0FuN3FWemV3WGc5bVhTOFJpUVRzMlg5R29zaHRsNGVtbi1kaWFRWkQ3WTFfWkNWSmIzbEFRa0N1YTd2MEE?hl=en-US&gl=US&ceid=US%3Aen
UVA Health among first in nation using new technology to treat irregular heartbeats	https://news.google.com/read/CBMiwwFBVV95cUxQV0JIME5OMHRkNEx6eXFXRk5idmJNaDVsM2FsZXNXSEVRdk5YNUtOUEVYbTc2TUNpU1BTNjhpb29YbVVicFZpS3QyeWlYNHc5NDVhb0w1UXh4bU1iam8tVGxQYVJyRFA1QkVxUHZDVDR4MDA0SG0wSF9TOTN6aExxVVEwdUhiMnRDOHFBMUJKc015ZjY2a1VfNGpqTHpEdzZkQWhQRDlBbmdZZE9Kd25JUkRLcEJEUjhVMkU1OExScUh3RTQ?hl=en-US&gl=US&ceid=US%3Aen
BIOTRONIK Expands Cardiac Rhythm Care by Launching World's First CRT-D Systems Approved for Conduction System Pacing	https://news.google.com/read/CBMi1wFBVV95cUxQLVR2N2xqZXZrVjBkdVBQUy1LNkFiNEhaMldkVGszYUpJWFIyZE5YU2ZPcTFjWjRUdHBfZ0Y3ZGQxUXNUMnUyUDMwNmtEZ1E2eldaR3ZZN2RkcEpBSUdiT1dhVXFPYzdhNnNuaG9YRWI2NG5wUW50RVNmN0dnWjFPZ1RCU3puUTJqa2QzSGdPWW1TM0Z3Q182VU1OeVFPODNGRmVIUFB6SGRmUHhvUkZkN0IySURuSnNkSUdySzBRQm1STks5VUlpVzFCMEttSDc0RlVvVjBHdw?hl=en-US&gl=US&ceid=US%3Aen
Barclays says Medtronic sees strong heart device growth	https://news.google.com/read/CBMisgFBVV95cUxOclBTYnNhNlctZDdwVXVQY0U4RDlhU3cwUzZTZFdjLThTWndWNmZkaVhqNjBBTzFXWGQ5bzd4bEMteTQyS1BGcURMaERzZFIwMGw5NTN6akZ0U1B2WEhpRm1QSVdCYmhZZUpLRUtQYU1naDBPYnRoR2ZpRkxReU9QblIzS0pOd0V3OTZoTHJlOUZVa0d6NW9SR2doRHVpUmRzVnBTemhaV0lxeWR4eHAyLXBn?hl=en-US&gl=US&ceid=US%3Aen
What is atrial fibrillation and how is it treated?	https://news.google.com/read/CBMicEFVX3lxTE1zaWRpT19GMFg3dEh0bDIwbGxYRzdSQTJjNWxxV01jQnp0aC1iY3k0dWstaGJTWm1PbmJQTU5vSHFxMXJVSGRDYXFjTUdZSEgwSEg5OVkwT0VnQ3hMSUdOXzQzRnFMXzBRdTJnQjI5NVQ?hl=en-US&gl=US&ceid=US%3Aen
UC Davis Health Expands Heart Rhythm Care Services	https://news.google.com/read/CBMigwFBVV95cUxNXzRtMndieWhEYUVlS1Y4ZGVHQ21YMGpJeTBkYzBDUHl2dWFoN3c3WGdEcUxucmdKVk9OeW9PcEFfQzJGTlFsdERJUVFQXzJWOE4zN3hrMmNEUDJWYmJ5TzJGTFVBSUlXUlVnWW9aWFJ4SXl5U2VqOEFHRGN5TVFqZXBhRQ?hl=en-US&gl=US&ceid=US%3Aen
Abbott Reports Strong Results for Amulet 360 LAA Occlusion Device	https://news.google.com/read/CBMipwFBVV95cUxQSkhqVS1vaDdfNUVEUjl2ZXZvSTdiUmdNMkVMTnZZZDNIR2hLZ1BrMmhnMjF1RTJaWmxZY0NNTDVkWVVnSHFoLW1ldUlLbnFEOUljRDZPM1Fiem1HRTVtMzZmaFZkYXZsNnVXUm1rRXRLeGxzdXR5Vzg2b2lPZFh5S1dmUlk2RU9VMnprOHF1d09aNHdrMlBnN0NqX0k3RjNUTzV5ZWVIOA?hl=en-US&gl=US&ceid=US%3Aen
Atrial fibrillation: First of its kind therapy for 'debilitating' heart condition	https://news.google.com/read/CBMiXEFVX3lxTE43OUo3cVBOZS1yTnc3UVQySElEdnA2UTM2aDR6UUJsWkstS3Z1YlVwbi1FbkJUaUxGcXFYZG9aNTFfTy1nZDIwT2lybFB0ZUhkdlVhZXFGS0xNZkpZ?hl=en-US&gl=US&ceid=US%3Aen
Oral Anticoagulant Discontinuation After AF Ablation: Review Sheds Light on Risks and Benefits	https://news.google.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?hl=en-US&gl=US&ceid=US%3Aen
PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data	https://news.google.com/read/CBMivAFBVV95cUxNMmFUQTNBbTIxMGdCRWNoZXdMdWFSc1F4VWpSOWVITFAyNlZyMzBnajdDZGtoaDVPOXA3Q0ZtTDFhRmtiOGhydmVlVnpyU0EyOHVCbkpYU093a0RxdXJtNVk1SGljUXpKbWtvUUFkNkFMb19kV1E5Wnpwd1ZqZlFIby1QUXEwT2YzbnA2ZWV6WWlWekZMd1B2MXVQMUIwYXJFVEpwR0k1eE9pNHVEc0tTR05BNzdMdTFuQUJBRQ?hl=en-US&gl=US&ceid=US%3Aen
Moderate exercise lowers atrial fibrillation recurrence after ablation	https://news.google.com/read/CBMi0wJBVV95cUxPRC1jc1dxenpUZW1wX0Fid282RTFCUDhoZnZTTjgyY2hWZWF2Z3JEa2lmY1Y1d25USkc2TGlLSVkxVm4wMk8xd3RXTzdqa2VHcGYxSzkwbzdXWVNjazFQUFBVdk9PMTZaMnhXdVFleE1MWVhvcVQtNWM0VldMSjlaOTloSVhUd0JFMlVacFU5aEQ4a1BidHRCY1RUNk1qRFZaa09naWpKdmF6NjZNYnFxaE9scmF6bklsUFNPVFdXZlg0bkFrSHZOMW54WDJHdHlmN3liYmRLalN3X2pLd3RnTmNmWkxzOUFIZkoxNFo5bVpDN09PcVpyTDJKZ21xV0FIX0NXWWhZUHNnVFhYLUQxdWxrT21ZdzUzWC1FQjdVclFSN0l5LUdGV2xWLUh6TE4yU2dubnV5cHpYdHpkWEQweDFlT1JmUUlneVhrempDYjNyRXc?hl=en-US&gl=US&ceid=US%3Aen
Hospital Trust among first in UK to trial novel procedure to treat heart rhythm conditions	https://news.google.com/read/CBMi1AFBVV95cUxQbDZVTmxXSDN1ZlE5OHcxclpYV3FtWmphUjAtVHBIWGNoblFqRC1INE5xdzdkdjIxMXdiY0VkSmhnWllYWnlBUUdHWHM2TWw2d1lyRFN2YkVGS0l1RnkyS0owc0ItaDN2RjRtbHdWYWpWc3FJbkFtMFQtR2hUTThTZ3N1cjJ1Zk1iZzM4LWNRU1NTSkVFWk1UblpQS25BUXFQdlpldnFKbGZTcFJ0bDE1dmQtTDdicFN4VFpDQUNvamU1akRJLS1fYWV3TWMwMUp1T2V5Zw?hl=en-US&gl=US&ceid=US%3Aen
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data	https://news.google.com/read/CBMisgFBVV95cUxNQWxtTXcxR0FQNVBUMm1oNkprcXpHXzBwX0xoNnNIaEstUkViQWVid0phbFdyMmd3dkRxTlhpWmNVaTI5NTBGbVV2Z1EyZ2QxRUhpZDYzVWpnRnota2VCM0RrTFcxQW9kWWg2bWJKM3BnZlFlTThPRFVaSDNmZ0hFUGttbC12RkVnMDJSdm83NjhsVWtfMlI1NWVXT2x0MFBTSHo5TzNFV0xoRWlFeTdiRUJn?hl=en-US&gl=US&ceid=US%3Aen
Hospital to trial 'innovative treatment' for people with common heart condition	https://news.google.com/read/CBMirgFBVV95cUxNamVRQXBsWTVaNDhYSmlPQWVoNGVaVnlYdF9zc21KRktGZ2U2QmZseGFyUGxCYW45UDdZaDRObzlRbW1VNHlDUTM1SzFPVUh2TXdCWnAzNzFvYzExcnR6eXZWQXF3OEhIRFRLTnEwdTQxYU1wZHJmYjVIazA2cXNCR0t0TE5BOGIwUFJjVF84b2pQaWxmNHVFVkV4VVhPS2tYYmw0REV2UDRwUUl1WFE?hl=en-US&gl=US&ceid=US%3Aen
Atrial fibrillation: Diagnosis remains remarkably straightforward	https://news.google.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?hl=en-US&gl=US&ceid=US%3Aen
Hospital to trial 'innovative treatment' for people with common heart condition	https://news.google.com/read/CBMioAFBVV95cUxOMFNieVV0TWY4em4yaEVuVEFvU2w1N3RySnVTZ01pY1NrelhocldUQVJwbTdPeXZLQlZYSTRLZ1hLMEJOT3hNdERxbkpNVDJLS3Z1aUVlbERMN1R0NDVucTJ0dWltUE5faS15RlpUUUdERXFsaExRd3J1LWtLSU1aTExMRFlrUnh4eHpFMnQxR2tFSzNvM05ocDNIODFRMEJn?hl=en-US&gl=US&ceid=US%3Aen
Abbott stock price: Insider buy and fresh AFib data put ABT back on watch for Monday	https://news.google.com/read/CBMipwFBVV95cUxNXy1VSkcyeUxQYnJCcE9VNlk3X1VaMVlhMGZzQTZzM0ZHUmR3STBvaVpIOWo5aTFtVXpHb1lVcUNzX2p0d3JIRW9iVU56SHRsSWpYVkVfaENtTUxtTWZiWExWU1JIQVNLYk1XQ283ekN0cG9KdXlxaGRweXdwYTVXZC15dS1RY21IY2VMTFFFdjJxZVhWQ2lmTEFrWnZVNnFaRmR0SmkwNA?hl=en-US&gl=US&ceid=US%3Aen
Abbott stock rises on AFib device data buzz as traders weigh FDA overhang	https://news.google.com/read/CBMioAFBVV95cUxNVkhpWmM4cGczR3h0YnZyNGFPSDBGaVFkNmNIV1VHSWRKOGJ1bER3S25WSThMYVpJV0FqVzY3VXZjYXVLWU92WmYxdXZiQy1La0E4MlFpbXYwVWFLSGQ4OFJzTmd2eFpiZ2diZ0dOX3BjRDhyc3FQbUswUExXQVRKNkZzQ3gyZUFISlVjMVRveVFKNDdoZ0ZxQjRWM0NCdG90?hl=en-US&gl=US&ceid=US%3Aen
Johnson & Johnson stock price: JNJ near 52-week high as talc ruling, heart-device data set up Monday	https://news.google.com/read/CBMiuAFBVV95cUxQZFdITUc4RmQwMVppOVpUYUxrbWIybmVOZHhRNHpLVVZBTzZtOUQwWkthcGE1ZnRJdUZLM1BIN0p0VUlBb3hFdzhPc2pjSTNHelBQbUhqNndERGxyVTlqZnJWSnFFd2prOXRZWl9nU2hzNmlxQThscWFvRGd5UWUxcVlFWHB6Y2JpckZZUDdpTVZXYS1MOC0tQzhiT19zVjVmXzR1T1VCTS1LOUlBMnBrdFhtWENoWGZ1?hl=en-US&gl=US&ceid=US%3Aen
Devon hospital to trial innovative treatment for people with heart condition	https://news.google.com/read/CBMirwFBVV95cUxNTDVWblRFSlFVcm10QmVKSUNYcHVPNmJld3pESlVpaEU3UDhHR21WMC1hc0Vnd0EwaEtYbFdOdm1zNG56b0NFa25CUS01c004R3cwcms5V3B6SjdJQ0RrSE0xWEdpYk52eExFakR0WXhpZ3hFM0V3SnpXMG1pTU91cldZRFd0OC1xN0I1eUw0TXM0SGZJa3FFQmRuZ3JFajNWMG9tNHRuX2dCYTdWcFVR?hl=en-US&gl=US&ceid=US%3Aen
NI hospital among the first trial new device to treat common heart condition	https://news.google.com/read/CBMihwFBVV95cUxPOUtMWWd3R2Q5MmF0Q1ExZEh6ZWp0cU9ITkxxYkZfWFoyOGFJWUZLcndMMkhFM1FoVTdiWkIzc2RsQkQ1U1I5bFd4eDNtMXdaUE0yb2Z2RzZDUy1ETDJVZm5tNFJDVXhqRllyWVFyeTdWNDl3cU9rRTI3TndqUUFucERpX1NzRm8?hl=en-US&gl=US&ceid=US%3Aen
Did you know if you have palpitations, chest pain it may be atrial fibrillation? Heart surgeon explains its dangers	https://news.google.com/read/CBMi_wFBVV95cUxNUHR1RDA2RkcwRUVRWGh3QXRPX2dDZlNvMXB5VU9MdzZHUkxkX0ozS1RSV3lJU0owTG1RZ1YzeEVoTnhKcnRGai1nSnViaEZvQUtnRHR5eUMxWU9UUHBoVDBFbVZkOFZYU29wNVJCNTNGOEkwcDExM29QZHlRVGIteFdaSGQzLUNtOHpsTlpNbFZXX0NHMXVqWnBhRW9qdXc1MHg4RFBCaVBKM0ZOTW1vQWllX01oLVpwaFFkN19EbmxDbjdDREpBbW9kQ2hkR0ZVN2t3YXEtYlpLTDBOWUJYQ0FZT3dUdjV0VDB3aFhtYWNqLS1lRWJ3el9vUlF6bHM?hl=en-US&gl=US&ceid=US%3Aen
New Studies Affirm Apple Watch's Efficacy in Early Atrial Fibrillation Detection, Bolstering Stroke Prevention Efforts	https://news.google.com/read/CBMi3wFBVV95cUxQOUdfbnhWREtpbkw5TzlqcXhNTy1fSDAzN3R0Tm9PdzNPRjNOc2x4bUxnbTZSVXdGMTljekJueUQ2RGt5STFudkp5Znl2RjRUTl9uQUJZVGFLY0l6cGo1QVlpeUVzaUpyaEktM3g4R09UNUFlT3RISUpvOHdSRW9HQnBWMF9LYjg3aHlsLTE2UE04b1pkNzdhRmZvY01tNEJJQjl2V1FSRFBZLWtFRmhKRDNOZzg4dks1dWx5LWphR2prNEdIQVg4NVg5dnZaQXJjSXBrX0pjcEtNSVo3Ukk4?hl=en-US&gl=US&ceid=US%3Aen
Technical Aspects of Lead Extraction Symposium: Interview With Program Director Robert Schaller, MD, on What’s Ahead in Lead Extraction	https://news.google.com/read/CBMi1wFBVV95cUxQc0dUaDlGMC0yak5vTzRIWm91ZFUzVld4NzRnUGxBWndZTU5sdlUwNmp4UjBNLXpwOWd1MjVkTmpJeVA5WGpzVVZ2N0pWOXZMNE1tdnE5a1pCMXZaVzVRQzNsRGpLZnpmaTdxZGVPRmp6Z2N1dWE0RENVMVMxTURDMXhxSFl4eXV3QWt3TlhoY3Y1NkhKYUU3V0JiWXhoUlFLUWhiNGlJYzNFejhYaWpLOVZiOHFOeklfM1JVakNrUlh6THg2cFJ2WU9YMThMb1VOREZHeFRKZw?hl=en-US&gl=US&ceid=US%3Aen
Within-visit and short- and long-term between-visit blood pressure variability as predictors of cardiovascular events and mortality in elderly Chinese	https://news.google.com/read/CBMiX0FVX3lxTE9pZjJHbUdIamUtR01FT2tCZVJkRWZucFo5Z0pFaGtteHJ4SEpGOHZmZkhFOXBrYmNWb3ktUDVaMTVMZmtMSUhrVVduRTc1a1FWYWxmYXhCWFRQdks2Rmk4?hl=en-US&gl=US&ceid=US%3Aen
Abbott announces late-breaking data from global VOLT-AF and FOCALFLEX studies	https://news.google.com/read/CBMirAFBVV95cUxObU9mUVd6Y0RFTEJ2QjdXSFJ1dllvVHVDbXBLLWhnRFNUVXdZNE05TWhjY19sOG9KQXZKekdkRm5NVEFScXlrMDlDYk5JLTUwbEF3M21nM2RTVGQwSS1CUzhBX2E1YUlOYkw5TG9aSmpiQk9xa2JoVGJKX1pmbVEtcDN1ZzctdnYyOUtaTzZkbzdET3MzVVQ4dkdvQkM2RWRlMzY0bEFVbmJpbGhJ?hl=en-US&gl=US&ceid=US%3Aen
Argá Medtech Reports Clinical Results of First-in-Human BURST-AF Trial of Single-Catheter PFA System	https://news.google.com/read/CBMixwFBVV95cUxPUXkyNTRfb2tra255QWc3VGdFbGtOMWRQV3RTdWdWSnRwNUdBNHY1ejJPQkItSDhJNGV6ZHlBWkZUOWZYamRBbE1wZGowenlOM1J6TE9FWDlJR2diUTI3UmFzZlpESHVibWt4M1JmR010YjZMMlNkd19rUEUyQ2VNaERDVXYtLUtiZVpwTkg3bVB5Y3RNclNzZHNHYjVOWFVWdi1qN3hsSWx0ZTREQXZuTlluZTE2WEUzRzkyTUVnSm04cVFFREVz?hl=en-US&gl=US&ceid=US%3Aen
Johnson & Johnson (JNJ) Reports 100% Success in OMNY-AF Study	https://news.google.com/read/CBMikAFBVV95cUxQUk1ubk9teWpaSm1jRWlsWHl2VlhEcVBRekVFcnQ5LXFTRDBLV3FTdzUyZElPbWVFSGNwSVRnLV9Hd2FDSlJVQWVKNFcxMG5ubDF3bjV3Z29CRTJjUXB3ZDlIVmVPV29XQXVzZ2ZNUTZ1SnY0V2Q5S0NTOFRiTVZjVHR1b2ZTOTVBU0N6YmxKRE4?hl=en-US&gl=US&ceid=US%3Aen
Edgewise Therapeutics Teases Phase 3 Sevasemten Readout, HCM Data Update at Guggenheim Conference	https://news.google.com/read/CBMi5AFBVV95cUxOMVNVSGdFRl9JV3BQMG54bUtsX0hHQU9fRnRYQlNlbThTSFg3V0FsNDRULW1hclAyM3UtbUp1d2I2Tklkdm9Na05FbkZOQUJZRUpSV1ZyQ2hJTF9MejlBdUQ5XzVMYVBibWROUnVYUGViWEpsVmFtTF9RZHFHb3R5OEhadEtSY2hnMWplQVFZNk0wd0RQdHI4V0FOZXVsOXpTUUpNOThINHFybkJLZDNKemZMUHppRXNfVUxPZEYxbjlZc2h3MnM3WEdaTjl2ZTNLSlV2QjNNX1Y1X2dhY1FBbnYtdEw?hl=en-US&gl=US&ceid=US%3Aen
Pulse Biosciences Highlights Strong AF Outcomes From NPulse Feasibility Study	https://news.google.com/read/CBMipwFBVV95cUxPSm1la0ZYYWlsQzA1U1BEOVQyc1A3OWVuV0gwMkpPRURNMjZTb2Rub3ItaWFDVnJKMThQRjJXdHg0VndpVWZ3UTZqcFptbXFGM0VzSmxXRUNGVlN6am11ZkctU3RPMmgtTlBSMjFMV2dRMzlHYVNpN1Q1WjlSeGJMcGZNc1VmUGZFbTBOcjdmTldVdHJBRVVRYnZqTjVaRE10Ulp6d3EtQQ?hl=en-US&gl=US&ceid=US%3Aen
From Monitoring to Prediction: How Cardiovascular Digital Twins Could Transform Arrhythmia Care	https://news.google.com/read/CBMi1wFBVV95cUxPRDJnVzVMOGQ5RWdzNHNsOUNqUFNSSXVfdkRLS2Y4S3lqN2dNYkNEbTFCcS1LYmFIWm55LThWV2k0WFRGZlhQTW9Db0lwdWlCVUY3bjczbWY4YkZ1MzVxZFVhcHNSTGh6OVRGWlpTOHphdW9SRGw5SVNHaFhhemVYT1Y0WTR2d3RWUjQ0VU84S2ZQV0dIMVBhbVdiZEtIdjRCMHM0eXhvUFB1WGE4TXA2M21xeklYR3RWdFRWRFRManYyMkJNOXRKODhFbllXY2V2QVBJS3BlYw?hl=en-US&gl=US&ceid=US%3Aen
Argá Medtech reports 94% lesion durability and “strong safety profile” with single-catheter PFA system	https://news.google.com/read/CBMiygFBVV95cUxNeFVzZ1Q2RlBMQWpqVmVGb2V6N1ZyajFUcHBqa2xYeFlkcGNJYXdTZlVLN0FWRU5fUjFvRmUzcnpJWG5WMFJNQ0swSzBzam91MzRLMXpPRzF5c05PUzVNSXZOUTRBcXl1U1VSbUpNOFB4MnZFN2YzYVB2M2NFWFFLZERuNkYyb0lMemZXNlNEQlRtMnZkSXFJWWxJTUFQUmJtXzhRb2xWSWU1UDNRaFZNQlpCa1lhdVdzNjkzaGlhbXhqbzZ1bkFTd2F3?hl=en-US&gl=US&ceid=US%3Aen
Pulse Biosciences presents latest data from first-in-human study evaluating nPulse cardiac catheter system	https://news.google.com/read/CBMi0wFBVV95cUxQaUxSM3VwakNlRnJYM0xIYnJ2cWVOVTFCVUxzd2tlLVBDajNib2F1VjNHemJZU2R4dGt4SGNKTE00VHZ4WEppSGUxdHBzWUthc2ZVb3BIcU43aC1NQXY5UXM0b1lERXc0TEZ5a0RvLXRwTzVKVGZDRDgzOXNyMzJVODBlclZYMEhuanp4WnBxTGlxYXRfWUZUdTNBYmxiWGdTVDQyTGxfVURZZ3dTSHM5NkFDR2F4LVRCYzZYN214Q0JyZkVHc1F3VWowWEZxc1lLb0FZ?hl=en-US&gl=US&ceid=US%3Aen
Pulse Biosciences (PLSE) Is Up 70.4% After Strong First-in-Human nPulse AF Data Release – Has The Bull Case Changed?	https://news.google.com/read/CBMi1AFBVV95cUxNTDBLNC1ZQkR2Smhudjl0bTVvOUFEbThJeFR4V0k5RDVvdTN3aUllTEJiNDZOSGxDRGNRY0dsV1llMTFnZG5oVmkyckUwYlg3QVQ5dzZfMnFEdDZhb0JTTk5PbFBjNzRocVVwbFp3QVVuNWhQMGNTUW9UV3ZneWZvcktXbEROdG01cU1iVGFOZTE5V25IdHNwUkJ1aEEyTnVkc294YVVQNFdnVWNGNFhfUEJTdkJNLWF1czdlbDg2ZWpUU1Rrd3FMWEtEZTBaS0lhV3VIaw?hl=en-US&gl=US&ceid=US%3Aen
Fatty acids predict disease before symptoms show	https://news.google.com/read/CBMikwFBVV95cUxOaWZaOXM3YlJDZ055eDVuaERydVNHNEExS25ua2pQUmtpaGc4RXNMcHFvY0hVVXBaS3hIamVSQzdEM3pBR0xGRHpHSUNCdEJabnRtUE5kN3h3NzhWYUpnSkZBUlBVU0c2QUZaQlpvU2E1Z3pvMDVCNG5MVGxWczgtSkNHOWt3QnpaUnhjNEpNSWdzcGc?hl=en-US&gl=US&ceid=US%3Aen
Argá Medtech Reports 94% Lesion Durability and Strong	https://news.google.com/read/CBMisAJBVV95cUxPaGd0NUlGZUQySmlENEhucWdNNGJ1VzVKRkdxbmNsbWd3ajZvOVpHbkFGdVZZaEhWbmZKZC0xNm42Z252X0tBUENvbGlCQ2RVQ19GMHZiRll3RTJVWEdPOEZoVk02YU9zdkRiQVJFek5XcVM3djFLckFpcFFSZlhOT0tKY3owZnRfcjVNTnV2V29YMXczeWJvTVhmQXZMaE1kUEYzLUtWRHBjcHlpbmdCNEFmQzJFY2F4MXppNWJuU1JPQVNCcWN0SFZ0dW9DQ2p6VjhEOWJuYVZLLXVJV3BraDBxck45RmgtT1hPS1dfcU5JSVhXdkFiYVE3Z3RsSUFEeDNHSDJGY3FRaGVrWWNzRUtNTUZjb3ZsSUtCMXlhLW1ud0VFVlcwZTNOWFNWOXMw?hl=en-US&gl=US&ceid=US%3Aen
Boston Scientific (BSX) stock price edges up after selloff; Farapulse data and March 28 CHAMPION-AF readout in focus	https://news.google.com/read/CBMizwFBVV95cUxPTWpvUjR3Y3NHeDZBZTY3OUx3MkhQd21TRVRpSmJPRHNEQ19GVWZGeC1naUgzMkx1bVpOaXBKTl9nVUpYTUt4RGxpTVpXZTBhTU1FRzN5MWlRd2RfcnllNmhRV1lKc0RtbFFhdHpJcDRLZi04a2thZVBrRmZRdVl5RjVEY3FpN1U3V1k2WEpDWjlpMmVjdXRzUHpySjctV0twZVhSYTVtSWViLVlrRFY3b1pYcXI4ZUFfU3pacjFVWUE2WGJSaW52djA4RTlmMXc?hl=en-US&gl=US&ceid=US%3Aen
Abbott’s Volt PFA System Enters U.K. Pilot Amid Expanding Atrial Fibrillation Market	https://news.google.com/read/CBMiygFBVV95cUxQQ0Vva1N5QVd4UkdfYy1uaEtzWkJhd2VIN0VQVkh6aXFEZEp6TE42N0NDcUJncWtxcHNVbUZnUmFaNVVXTmJPQ1hWaGgzejJfa3hYVm5FbXMwWU1VYnlGOHNoMXFSVWlsWGtiRTc4QXpsZTQ1WVIxblIwLTY4MU1EOW9xdGR3SU5oQUZ3Z0xDQkJ2UlhuQ1ZZNE5LNFlibl9RQUhXWGJVX1N2UlN1ZXY2Ukc0dkFkNmptZVB2WkdFRG83OHhrZG5ZOGRB?hl=en-US&gl=US&ceid=US%3Aen
Abbott Volt PFA Pilot Signals Intensifying Competition in Atrial Fibrillation Market	https://news.google.com/read/CBMizAFBVV95cUxOaVdneHpVbzlGSDJrak5zdldSMHhnYmRCZVJoMlljbDZqYnlSMk5QeXViWm1UWHNud1RrVDAwd3gyX0dfZ3QtRDdieG54bV9nNVpqbU5XdHhPZUhGcm93bUpfc25sNHlvQWFnV3pscTkyM180Wng0dmdwa0VNZzRER1hDUlk5YUtEWFVKV0dOX0thWVVfZWFISVd1aTFQcUZGSmtLSGdYeDg5ZzFhVXZkQW0wcEFoRGw0NXREZEd4VDNfeW1MekpSNVgyNVk?hl=en-US&gl=US&ceid=US%3Aen
Hospital to trial 'innovative treatment' for people with common heart condition	https://news.google.com/read/CBMiqAFBVV95cUxQOG9KZWpxa1hySVRZRDRtMzhLQWU1aWZZMF8ycVVBRDJvVk9KanlHLVJUV0RaVDJNZTh0V1Z2UWNZX1Bza3NPakhoSC1QQklaM2ZwMmwtdWRCU0c4QWFfM0dIZm1ySmJ4Vl9BZWtmOWxUMFBTN3p0dXhLODAzVzJBVFZTLUw5LWwzQ0tFUjZlQ1hwWWNxY29OSktGaHBiUWJUbVBqNFNJQzU?hl=en-US&gl=US&ceid=US%3Aen
Volta Medical’s RESTART trial provides “promising findings” on AI solutions in recurrent AF	https://news.google.com/read/CBMiuwFBVV95cUxPcjJ4d3RYamNXM2JWQ1R1UzNzemt0bFpIaGJ6bnM3RW9OOEFfSURuTDdIM3hJUTI0MF96SUZkVnZLX3dXOXk5eS1TcjdBTGJ3eWFTMTVXQ0JPc1hHd2YyWnp0c3huNmw4VXZDVENNVFRidHR5QndpUmFxZDJ2d0lOQWlxTWIwd1pUNnhyekZ3WFQ3OGdPZkYwTDllZTFzUGdHaUhGU1lyb2FQS1ktM2pBb2dRdkxQOHROR3FV?hl=en-US&gl=US&ceid=US%3Aen
J&J presents early outcomes from OMNY-AF pilot study alongside new Varipulse platform data	https://news.google.com/read/CBMivAFBVV95cUxOR1BneEMtZXROSkVpTUpaT3lndDZVV25mRzN3MjZjc3hJTC1id0RBaWY3TldLemFhQVVxRGtPTVV2RWxoUVQ4VDRZVnBJX0lteVBoME9PQzVWRWNZejlETjNERGE1aXhocjl6QVBpMU9qT2xvaS1fdG51UWpDZER1NDItX3VnZ00ySHFmdVFKZ203NG1odFNPRmtnRkNVRlREcS1ZZEdWZzFjWUdXM21VTHBLMzZFTGFpYW8tTg?hl=en-US&gl=US&ceid=US%3Aen
Biotronik launches “world’s first” CRT-D devices approved for conduction system pacing	https://news.google.com/read/CBMitAFBVV95cUxNTWtOSm1penRQVm04cnVRVTUyYkZqYWpxNGk4dWJ3LTUzUVhqWnpwWjFQSnFSbnd1bXhxTS1tVjkwSXZoNFcwUmluTXlKTklRSVpGaHQwU1l5OXFhRWtHVjlaUUpYR2FicjgxWVp0cmgtTm5jWFQ3bUdvYWIyZFl3RzVHdHREbW9FQjRPU05OUXlmekhRaFZ6ZUFPdjA3UDExRXMxZ2RjTGlEYVQ1VGx1c3l1aFY?hl=en-US&gl=US&ceid=US%3Aen
Field Medical presents late-breaking Field PULSE trial data at 2026 AF symposium	https://news.google.com/read/CBMisAFBVV95cUxPYXFYU3kxMTlYbC1FUmU3XzRHSUIxSlhud2NmSEtVVmdRUXNRNWtJNnRKbHRkY0FhMlZIVXg4Tkp3Mm1TUGpvV3pxSWNlMVhyQmNuMnVqdHJHOGlMQnV1d3V3aHZMV1Byd19qTHo5ekhRc0JrTktqcE9jelNXRXVvWWRqT2RrX1Zja01DTTZjWHN2OF8xY3NLSUNmWjI3V3FIZktkWmR0YWh3VmhlU3NrNg?hl=en-US&gl=US&ceid=US%3Aen
Clinical Trials	https://news.google.com/read/CBMiX0FVX3lxTE9xSmUyd0U0MnlNVlBCaG55ZF9kVzVqZ0FJbE91Zlh1Zml2TmE5SGp6UnNLTXVHZGJsYVFQcXdBYkZrVm81cEFVM1d2ZENaUzg4clluTVMwN0tnM2tuOUFn?hl=en-US&gl=US&ceid=US%3Aen
Medical Technology News | MedTech Dive	https://news.google.com/read/CBMiQkFVX3lxTE9hZlN4SmZSNXV4ZmNTUEc2SzZUdHFQSFJDRUNuUWxVNGZSQUNSQndDYi1iSGx5R3o1RXU5Y3dlazFTZw?hl=en-US&gl=US&ceid=US%3Aen
Medical Device News	https://news.google.com/read/CBMiX0FVX3lxTE11TXg2eXFMbDlpTVZjYV9NT3RhTU5LdlhMcVA0c2Vjc0hhZFdTZWJlZzV2dzdzOFozWlU0TzVIT214dW1lYXNFMHRWeWluNDZ6LXJiZGZ0cDBzcVJtWVZv?hl=en-US&gl=US&ceid=US%3Aen
MedTech Policy and Regulation	https://news.google.com/read/CBMiYkFVX3lxTE9JWFV5akJJYlkxWS1BVXhkZFdPRHBiU0xMM2RTX2NGQ3JBQ1dYZm9KZTN6eVVxYzdBN3NJS3Zhd2JTRm9CNVJwRGdqVU9RVjJKX1V5RzE5UENUN3did1BHc2FR?hl=en-US&gl=US&ceid=US%3Aen
Latest Medical Device News on MassDevice	https://news.google.com/read/CBMibkFVX3lxTFAzZTMtRFZSNWs1TGdpWmRmeTMtbWxPejE0bmxIR0dhcnNsM3VYTXBkak1id1RvWHNtd1J3ekJ4UWYxS1d0NjdOc0ViYmxzOGpsYml0ZWsxNkl1ZnI1LTVhWWRSSVRiV2dsREJ4LTJn?hl=en-US&gl=US&ceid=US%3Aen
Medtronic U.S. cardiac ablations business more than doubled in Q3	https://news.google.com/read/CBMilwFBVV95cUxQMmF2STZLa2doMU1SeVM4dHgybUluSlQtR0M5dnFrWmlHOGJQVVE4enZRT2w4aDc3TVFaX1RtZUN4QzlsQkV4VmszRWxZTnR6V2hfcDdnWTFHdjRNMDJsZmxqUGdmcTBYRVJXdXFRdFN3bDRsY3Z1bk1yaVNsWDRkR1JHZnBvdktPdDZadHdDRXBiVmZ1Z3Jn?hl=en-US&gl=US&ceid=US%3Aen
Medtronic stock gets a ratings boost on new products	https://news.google.com/read/CBMihwFBVV95cUxNOHQ5V2VUNzhXQUg0ZEc0bS1KZy1ZNU5EaHZSNkFuLVFKLUo1MloySmc0ZExaZmlBT2ZTLXRFcEx5cXBKR2l4dmxWMFpmSHF5UlRZcDBWMWVIdjNvSmd5aTd4MjhlNnV3YUtUMWhVLV8tSXV5bG5EREhDbERWbHJQSm9QZGpEM1k?hl=en-US&gl=US&ceid=US%3Aen
Today on MassDevice	https://news.google.com/read/CBMiQEFVX3lxTE9NOWVkOFZWLTd1R0JIdF9qRHJrbjZNcFVRS2czam9lVTdyM0FDTUpaOVY3Mnk5dktZd0JUNEdKemc?hl=en-US&gl=US&ceid=US%3Aen
OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding	https://news.google.com/read/CBMingFBVV95cUxOSnEwZlUxYllFSXZRVThLdTFQejVUaFBvVUt0SDVSV0JmR291SXlEeUtzQzE2Wlp6UmUtTkJ3TGZLZDZPNnRhbjdheXVTZnZDeE1MR0pVTGwzdVV4cS1IMkswcWlGMVBVRFV1Y3g2X0tBV3hZQjFobGlRNTY5UFRrczlXLVEwWXJOUVQ0cVZMSGdWQzN6RW1vQVNsdmRaZw?hl=en-US&gl=US&ceid=US%3Aen
Q&A: Lior Jankelson on AI Tools for Suspected ACS and More	https://news.google.com/read/CBMiggFBVV95cUxQNXlMd09hVFIzVGNhSFl1RF9lVnZJdVNZM3N1Y2RfeTJQSWhKVUhfRTh2TnVlZTBOTENqZjU1WHBSZVpPamI4SWtoVHpUVTVYVEtjU0hFcDF6b05mRWlQUzNrVW01d1hCR2NaNVQyLURsQzZhM0RIcHFKLWg4UUl5VmZR?hl=en-US&gl=US&ceid=US%3Aen
Meta-analysis Teases Out What Drives Success in M-TEER	https://news.google.com/read/CBMihAFBVV95cUxOUFhrelMtY1h5MHl0SVY1Qjl5WXg2UmlRVlduQnEyUlNhT1VkanR5RHJCaVN4bk5idWJLU1RIb19nYVVXdElFSTdPR0pnZmRpTEVya3JvUWZJZF9TM1I3UFN5LXl6a0ItTzlHdUYtSEpNN0s2N3J5RUJIZWZJanIxZzBaX2Y?hl=en-US&gl=US&ceid=US%3Aen
A safety update for cardiologists | AF Symposium 2026 | Catheters recalled | Nasal spray for PSVT | Key FDA approvals	https://news.google.com/read/CBMi7AFBVV95cUxPaUFGdzJmaG9SenZiYUNKR1BKUkhXX0ZfSkZwZktuNjZRUWNrZm5Ub1F6UDhxZnZMcm5iMzYwQkZydkkyUGhsLS11RUJFUHdnT3l3VHJJMjJQNUVUZ2N4eU5XTXU3TDltOXc2TWI5TDFINEEwN3JFTTNSUWxBVE1UeTJXSEhjSGFtQWF0NHhWeVlPbUUtQkoxbm93N2Y2U2Y2NTg5VXNUVW9SaHV2alJxRm9xdGVQVHpxLXNSTmozczdnZDNvOFYzSUt0QThVM1RfazdqOWJKTlFGUFJVQlQ1MjlOVmFUM0d3eWxoVQ?hl=en-US&gl=US&ceid=US%3Aen
Boston EP Party: New data presented at AF Symposium 2026 | Where Impella use falls short | A major safety update	https://news.google.com/read/CBMi5wFBVV95cUxPcWdqR1lTZjhzYjNYcDZHTHNYOTc1WkFha2dCek1JcndGaUVuZUhMelotTmItRTR6cnZjWGd3N2t0dEZzV0NCUUU2WG5lU1dkX2ZOQTZVNjJiYVBJQXZSM3JIdlRhUS1MWmU2dXRJTzE1aVVfbmZ3NEpNSnJkTU5qYUhJSmk1bUgtQ3dCRzhPTm03aUNoN0VpTnFTUnJEY2ZvSXlIVVRuTEUyekFHVGFUTGNWeWNsZmNhczNNcElQT1NYLUZlQlBsVUhsa1JOYkN3V0NzaUstWGNfVEpCQ1RJYkh0dnpuSmc?hl=en-US&gl=US&ceid=US%3Aen
ECG market keeps evolving thanks to AI, home monitoring and Epic integration	https://news.google.com/read/CBMi6gFBVV95cUxPN3FPTEVpa2JtandMb1pVaEttdHVpcjduSVRFenY4REczSkhnRjNQbjEtQURkNkZaRy10NGJfa2tfZnBVczF4NW00MHRTVXZhclA1Z1F4Q1o4NV9LaGozalVibmlKbHVlZ0ptaTRvZEhUaHhuRlBfbXNPeEpxTjBodEtKX3BKU1prTzVHc3VZcTQ3T0RoRGZSajhRSWtKUzc3bURJcUtLbHdyV1lrSkx2cXZPOV9FZWJhUkpmNzIyNHJsWTVmcUxBQUV4YTFRRWFoRllzcEM4Rkw4RGJocjBWZG9sZmxFdFczWUE?hl=en-US&gl=US&ceid=US%3Aen
Get News Alerts by Email	https://abbott.mediaroom.com/alerts?type=1
Late-breaking data show positive safety outcomes and closure rates for new Abbott device designed to reduce stroke risk in non-valvular AFib patients	https://abbott.mediaroom.com/press-releases?item=124733
Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation	https://abbott.mediaroom.com/2026-02-06-Late-breaking-data-presentations-showcase-the-safety-and-efficacy-of-Abbotts-ablation-catheters-to-treat-people-with-atrial-fibrillation
Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms	https://abbott.mediaroom.com/2026-01-20-Abbott-receives-CE-Mark-for-the-TactiFlex-TM-Duo-Ablation-Catheter-to-treat-patients-with-abnormal-heart-rhythms
Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation	https://abbott.mediaroom.com/2025-12-22-Abbotts-Volt-TM-Pulsed-Field-Ablation-System-Receives-FDA-Approval-to-Treat-Patients-with-Atrial-Fibrillation
Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart	https://abbott.mediaroom.com/2025-12-18-Abbotts-Amplatzer-Piccolo-TM-Delivery-System-Receives-FDA-Clearance-and-CE-Mark-to-Optimize-Procedures-for-Premature-Babies-With-a-Hole-in-the-Heart
Abbott initiates medical device correction for certain FreeStyle Libre® 3 and FreeStyle Libre 3 Plus sensors in the U.S.	https://abbott.mediaroom.com/press-releases?item=124718
Acesion Pharma starts Phase 2 trial of AP31969 in patients with atrial fibrillation	https://acesionpharma.com/acesion-pharma-announces-initiation-of-phase2-trial/
Acesion Pharma announces Nature Medicine publication of clinical results in Atrial Fibrillation	https://acesionpharma.com/acesion-pharma-announces-nature-medicine-publication-of-clinical-results-in-atrial-fibrillation/
Positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint met	https://acesionpharma.com/positive-phase-2-data-from-atrial-fibrillation-clinical-trial-primary-endpoint-met/
Acesion Pharma Announces Positive Results for Novel Drug Targeting Atrial Fibrillation	https://acesionpharma.com/acesion-pharma-announces-positive-results-for-novel-drug-targeting-atrial-fibrillation/
Atrial Fibrillation	https://acesionpharma.com/atrial-fibrillation/
February 10, 2026Argá Medtech Reports 87.6% Freedom from AF/AFL/AT at 12 MonthsArgá Medtech Reports 94% Lesion Durability and Strong Safety Profile in First-in-Human BURST-AF Trial of Single-Catheter PFA SystemContinue Reading	https://argamedtech.com/news/f/press-release-arg%C3%A1-medtech-reports-94%25-lesion-durability
September 19, 2025First Enrollments in COHERENT-AF IDE Clinical TrialSecond generation pulsed field ablation system will be evaluated in paroxysmal and persistent atrial fibrillation patients to gain FDA approvalContinue Reading	https://argamedtech.com/news/f/first-enrollments-in-coherent-af-ide-clinical-trial
April 27, 2025Initial Results of the BURST-AF StudySine Wave Electroporation in Patients with Atrial Fibrillation – Initial Results of the BURST-AF StudyContinue Reading	https://argamedtech.com/news/f/initial-results-of-the-burst-af-study
April 24, 2025HRS PFA Summit Live CaseEarlier today [Thursday, April 24] at #HRS2025, Dr. Ante Anic performed a live case during the PFA Summit featuring Argá Medtech's Coherent Sine Burst Electroporation (CSE) System. The system features pulsed field energy...Continue Reading	https://argamedtech.com/news/f/hrs-pfa-summit-live-case
April 8, 2025Argá Medtech Presented BURST-AF Case Study at EHRA 2025At the recent EHRA 2025 Congress in Vienna, Dr. Ivan Sikiric presented a case study using the Coherent Sine-Burst (CSE) Ablation System in the BURST-AF study. The case highlights advancements in procedural efficiency and...Continue Reading	https://argamedtech.com/news/f/arg%C3%A1-medtech-presented-burst-af-case-study-at-ehra-2025
January 10, 2025AF Symposium 2025Argá CSE PFA system preliminary results will be presented at AF symposium in Boston on January 16th at 8.30AM during the Spotlight Session – New and Emerging Technologies in Arrhythmia Management. Dr Ante Anic from KBC S...Continue Reading	https://argamedtech.com/news/f/af-symposium-2025
October 29, 2024Argá Medtech presents at SCRN 2024Dr Sabine Ernst presented today at SCRN2024 the latest feasibility data for ventricular pulsed field ablation (PFA) in an in vivo healthy swine model using coherent sine-burst electroporation (CSE) . The data shows that ...Continue Reading	https://argamedtech.com/news/f/arg%C3%A1-medtech-presents-at-scrn-2024
February 27, 2024Argá Medtech SA closes Oversubscribed Series BPulsed Field Ablation Innovator Argá Medtech Announces €54 Million Oversubscribed Series B Capital RaiseContinue Reading	https://argamedtech.com/news/f/arg%C3%A1-medtech-sa-closes-oversubscribed-series-b
Thrombopoietin inhibition abrogates JAK2V617F clonal expansion in a murine model of myeloproliferative neoplasm	https://meetings-api.hematology.org/api/abstract/vmpreview/302346
Evaluating reversal strategies for long-acting factor XI antibodies: NovoSeven®, FEIBA®, Kcentra®, novel FXI mutants, and an anti-idiotypic antibody	https://meetings-api.hematology.org/api/abstract/vmpreview/302867
Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial	https://www.nature.com/articles/s43856-024-00575-y
Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial	https://www.ahajournals.org/doi/10.1161/ATVBAHA.123.319692
Endogenous Protein C Activation with AB002 Improves Outcomes in a Rat Model of Acute Ischemic Stroke	https://ashpublications.org/blood/article/142/Supplement%201/3949/501088/Endogenous-Protein-C-Activation-with-AB002
Contact Activation Inhibitor, AB023, in Heparin-Free Hemodialysis: Results of a Randomized Phase 2 Clinical Trial	https://ashpublications.org/blood/article/138/22/2173/476071/The-contact-activation-inhibitor-AB023-in-heparin
A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain	https://ashpublications.org/blood/article/133/10/1152/272753/A-mechanism-for-hereditary-angioedema-with-normal
Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial	https://www.ahajournals.org/doi/10.1161/ATVBAHA.118.312328
Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke	https://www.ahajournals.org/doi/10.1161/STROKEAHA.110.603811
Jeffrey L. Saver, M.D. Carol and James Collins Chair, Department of Neurology, UCLA Founding Director, UCLA Stroke Center Distinguished Professor and SA Vice Chair for Clinical Research, UCLA Interim Co-Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA	https://www.aronora.com/#jeffrey-l-saver-m-d-12
David Gailani, M.D. Professor of Pathology & Microbiology & Immunology, Vanderbilt University Professor of Medicine, Division of Hematology Oncology, Vanderbilt University Director, Clinical Coagulation Laboratory at Vanderbilt University Hospital Ernest W. Goodpasture Chair in Experimental Pathology for Translational Research, Vanderbilt University	https://www.aronora.com/#david-gailani-m-d-13
Scott D. Berkowitz, M.D., FAHA, FACC Research Professor of Medicine, Cardiology and Hematology, University of Colorado Clinician-Scientist at CPC Clinical Research	https://www.aronora.com/#scott-d-berkowitz-m-d-faha-facc-15
Aronora Appoints Industry Leaders to Drive Next Phase of Growth January 8, 2026	https://www.aronora.com/press-release/aronora-appoints-industry-leaders-to-drive-next-phase-of-growth/
Aronora Announces Clinical Data to be Presented at the 63rd American Society of Hematology Annual Meeting December 6, 2021	https://www.globenewswire.com/news-release/2021/12/06/2346533/0/en/Aronora-Announces-Clinical-Data-to-Be-Presented-at-the-63rd-American-Society-of-Hematology-Annual-Meeting.html
Aronora Reports Positive Topline Data from Phase 2 Study of AB023 in Hemodialysis Patients July 19, 2021	https://www.prnewswire.com/news-releases/aronora-reports-positive-topline-data-from-phase-2-study-of-ab023-in-hemodialysis-patients-301336200.html
Aronora Announces Clinical Data to be Presented at the 62nd American Society of Hematology Annual Meeting December 2, 2020	https://www.prnewswire.com/news-releases/aronora-announces-clinical-data-to-be-presented-at-the-62nd-american-society-of-hematology-annual-meeting-301183158.html
Wall Street Journal Mar 21, 2024 New Blood Thinners Will Prevent Blood Clots Without Causing Bleeding	https://www.wsj.com/health/pharma/blood-thinners-prevent-clots-bleeding-abd9fdae?gaa_at=eafs&gaa_n=AWEtsqe2KjlRmyh9iE1YaG9iGmZUE-UGRkzfMpUG8KSWcODMGzH2Kch3vD7T-nb46w0%3D&gaa_ts=6928a345&gaa_sig=Ly91chzVDQT9QqwQI5RiiKDi9u2zXg_j6YDKxlwe7y55NDdyD2Ur1QjQN-HoigF_jbO2zsDkwcBC5Nsh6FfCRw%3D%3D
Concomitant Surgical Ablation Therapy »	https://www.atricure.com/healthcare-professionals/therapies/concomitant-surgical-ablation
Ablation Sensing Unit & Switch Matrix	https://www.atricure.com/healthcare-professionals/therapies/concomitant-surgical-ablation/ablation-sensing-unit-switch-matrix
Coolrail® Linear Pen	https://www.atricure.com/healthcare-professionals/therapies/concomitant-surgical-ablation/coolrail-linear-pen
cryoFORM® Cryoablation Probe	https://www.atricure.com/healthcare-professionals/therapies/concomitant-surgical-ablation/cryoform-cryoablation-probe
cryoICE® Cryoablation Probes	https://www.atricure.com/healthcare-professionals/therapies/concomitant-surgical-ablation/cryoice-cryoablation-probes
Isolator® Linear Pen	https://www.atricure.com/healthcare-professionals/therapies/concomitant-surgical-ablation/isolator-linear-pen
Isolator® Synergy™ Clamps (OLL2/OSL2)	https://www.atricure.com/healthcare-professionals/therapies/concomitant-surgical-ablation/isolator-synergy-clamps-OLL2-OSL2
Isolator® Synergy™ EnCompass® Clamp	https://www.atricure.com/healthcare-professionals/therapies/concomitant-surgical-ablation/isolator-synergy-encompass-clamp
Isolator® Transpolar Pen (MAX1)	https://www.atricure.com/healthcare-professionals/therapies/concomitant-surgical-ablation/isolator-transpolar-pen
Lumitip™ Dissection System	https://www.atricure.com/healthcare-professionals/therapies/concomitant-surgical-ablation/lumitip-dissection-system
Multifunctional Ablation Generator (MAG)	https://www.atricure.com/healthcare-professionals/therapies/concomitant-surgical-ablation/multifunctional-ablation-generator
EPi-Ease™ Epicardial Access Device	https://www.atricure.com/healthcare-professionals/therapies/epicardial-access/epi-ease-epicardial-access-device
Isolator® Transpolar Pen (MAX5)	https://www.atricure.com/healthcare-professionals/therapies/concomitant-surgical-ablation/isolator-transpolar-pen
Left Atrial Appendage Management »	https://www.atricure.com/healthcare-professionals/therapies/LAAM
AtriClip PRO-Mini® Device	https://www.atricure.com/healthcare-professionals/therapies/LAAM/atriclip-exclusion-system/atriclip-pro-mini-device
AtriClip FLEX-Mini® Device	https://www.atricure.com/healthcare-professionals/therapies/LAAM/atriclip-exclusion-system/atriclip-flex-mini-device
AtriClip® FLEX•V® Device	https://www.atricure.com/healthcare-professionals/therapies/LAAM/atriclip-exclusion-system/atriclip-flex-v-device
AtriClip® FLEX™ Device	https://www.atricure.com/healthcare-professionals/therapies/LAAM/atriclip-exclusion-system/atriclip-flex-device
AtriClip PRO•V® Device	https://www.atricure.com/healthcare-professionals/therapies/LAAM/atriclip-exclusion-system/atriclip-pro-v-device
AtriClip PRO2® Device	https://www.atricure.com/healthcare-professionals/therapies/LAAM/atriclip-exclusion-system/atriclip-pro2-device
AtriClip PRO® Device	https://www.atricure.com/healthcare-professionals/therapies/LAAM/atriclip-exclusion-system/atriclip-pro-device
Atrial Lift System	https://www.atricure.com/healthcare-professionals/therapies/minimally-invasive-surgical-instruments/atrial-lift-system
Active Clinical Trials	https://www.atricure.com/healthcare-professionals/clinical-evidence/active-clinical-trials
Trials with Results	https://www.atricure.com/healthcare-professionals/clinical-evidence/trials-results
Atrial Fibrillation »	https://www.atricure.com/patients-caregivers/atrial-fibrillation
Symptoms, Risk Factors and Triggers	https://www.atricure.com/patients-caregivers/atrial-fibrillation/symptoms-risk-factors-and-triggers-atrial-fibrillation
Importance of Treatment »	https://www.atricure.com/patients-caregivers/atrial-fibrillation/importance-of-treatment
How Do I Find Treatment	https://www.atricure.com/patients-caregivers/atrial-fibrillation/importance-of-treatment/how-to-find-treatment
Diagnosis and Treatment Options »	https://www.atricure.com/patients-caregivers/atrial-fibrillation/diagnosis-and-treatment-options
Diagnosing Atrial Fibrillation	https://www.atricure.com/patients-caregivers/atrial-fibrillation/diagnosis-and-treatment-options/diagnosing-atrial-fibrillation
Frequently Asked Questions	https://www.atricure.com/patients-caregivers/atrial-fibrillation/frequently-asked-questions
Active Clinical Trials	https://www.atricure.com/patients-caregivers/clinical-evidence/active-clinical-trials
Trials with Results	https://www.atricure.com/patients-caregivers/clinical-evidence/trials-results
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial	https://ir.atricure.com/news-releases/news-release-details/atricure-announces-first-patient-treated-boxx-noaf-clinical
AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following Amputation	https://ir.atricure.com/news-releases/news-release-details/atricure-announces-launch-cryoxttm-device-post-operative-pain
AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention	https://ir.atricure.com/news-releases/news-release-details/atricure-completes-enrollment-leaaps-clinical-trial-stroke
Concomitant Surgical Ablation Therapy	https://www.atricure.com/healthcare-professionals/therapies/concomitant-surgical-ablation
Left Atrial Appendage Management	https://www.atricure.com/healthcare-professionals/therapies/LAAM
Atrial Fibrillation	https://www.atricure.com/patients-caregivers/atrial-fibrillation
Importance of Treatment	https://www.atricure.com/patients-caregivers/atrial-fibrillation/importance-of-treatment
Diagnosis and Treatment Options	https://www.atricure.com/patients-caregivers/atrial-fibrillation/diagnosis-and-treatment-options
